ABOUT THIS EPISODE
What if ageing really is something we can engineer around?
This week, we head to London’s HowTheLightGetsIn festival, where thinkers including Bryan Johnson and Aubrey de Grey are debating whether humans could ever truly overcome ageing. Then we look at a one-time CRISPR treatment that cut LDL cholesterol by roughly half — with the effect still holding a year later.
Finally, we dig into the darker side of powerful new medicine: Novartis pausing eight CAR-T trials after three patient deaths, and what that says about the risks of trying to reboot the immune system.
English
United States
TRANSCRIPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
SEARCH PAST EPISODES
Search past episodes of This Week in Longevity.
OTHER EPISODES IN THIS PODCAST
Can we delay menopause? Could a simple blood test predict Alzheimer's years before symptoms appear? And can AI learn to read your brain? This week, we unpack three of the biggest breakthroughs in longevity and preventive medicine: a potential new way to slow ovarian aging, a groundbreaking Alzheime…
Why are investors suddenly pouring billions into longevity? This week, we unpack Retro Biosciences' $1.8 billion mission to add 10 healthy years to human life, the blood test claiming to reveal your body's "real" biological age, and how Google's AI drug company is trying to reinvent how m…
Could Bryan Johnson's latest venture transform women's health? Can the bacteria living in your gut influence how fast you age? And could AI soon help diagnose depression from a simple brain scan? This week, we unpack Bryan Johnson's bold expansion into women's health through Immortals, a new study …
We examine why RFK Jr.'s push for peptides has sparked one of longevity medicine's biggest debates, why Halle Berry is betting on menopause care, and how a new AI-powered wearable aims to estimate hormone levels without blood tests. Are these genuine breakthroughs—or is consumer demand moving faste…
Apple's latest AI announcements suggest the company's biggest healthcare push yet—but is it on its way to becoming your first stop for medical advice?
Next, we explain why the FDA is tightening the rules around compounded Ozempic, what it means for patients, and how the GLP-1 revolution is continui…
Disclaimer: The podcast and artwork embedded on this page are from Studio Talbot, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
EDIT
Thank you for helping to keep the podcast database up to date.
